Guard Therapeutics announces changes in number of shares and votes
Kurs
+2,94%
Likviditet
0,15 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-02-20 | 08:30 | Bokslutskommuniké 2025 |
| 2025-11-13 | 08:30 | Kvartalsrapport 2025-Q3 |
| 2025-08-21 | 08:30 | Kvartalsrapport 2025-Q2 |
| 2025-05-06 | N/A | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2025-05-05 | N/A | Årsstämma |
| 2025-05-05 | 08:30 | Kvartalsrapport 2025-Q1 |
| 2025-03-06 | - | Extra Bolagsstämma 2025 |
| 2025-02-20 | - | Bokslutskommuniké 2024 |
| 2024-11-13 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-22 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-05-08 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-21 | - | Bokslutskommuniké 2023 |
| 2023-12-15 | - | Split GUARD 50:1 |
| 2023-11-10 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-10 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2023-05-09 | - | Årsstämma |
| 2023-05-09 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-24 | - | Extra Bolagsstämma 2023 |
| 2023-02-22 | - | Bokslutskommuniké 2022 |
| 2022-12-13 | - | Extra Bolagsstämma 2022 |
| 2022-11-16 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-23 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-13 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2022-05-12 | - | Årsstämma |
| 2022-05-12 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-22 | - | Bokslutskommuniké 2021 |
| 2021-11-18 | - | Kvartalsrapport 2021-Q3 |
| 2021-11-08 | - | Extra Bolagsstämma 2021 |
| 2021-08-19 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-14 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2021-05-12 | - | Årsstämma |
| 2021-05-12 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-24 | - | Bokslutskommuniké 2020 |
| 2020-11-18 | - | Kvartalsrapport 2020-Q3 |
| 2020-09-07 | - | Extra Bolagsstämma 2020 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-15 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2020-05-14 | - | Årsstämma |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-27 | - | Kvartalsrapport 2019-Q3 |
| 2019-10-23 | - | Extra Bolagsstämma 2019 |
| 2019-08-27 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-31 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2019-05-29 | - | Årsstämma |
| 2019-05-21 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-20 | - | Bokslutskommuniké 2018 |
| 2019-01-24 | - | Extra Bolagsstämma 2018 |
| 2018-11-21 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-06-01 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2018-05-31 | - | Årsstämma |
| 2018-05-23 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-23 | - | Bokslutskommuniké 2017 |
| 2017-11-22 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-25 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-24 | - | Kvartalsrapport 2017-Q1 |
| 2017-05-19 | - | Split GUARD 20:1 |
| 2017-04-28 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2017-04-27 | - | Årsstämma |
| 2017-03-14 | - | Extra Bolagsstämma 2017 |
| 2017-02-22 | - | Bokslutskommuniké 2016 |
| 2016-11-18 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-19 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-03 | - | Extra Bolagsstämma 2016 |
| 2016-04-28 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2016-04-27 | - | Årsstämma |
| 2016-04-22 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-19 | - | Bokslutskommuniké 2015 |
| 2015-11-02 | - | Extra Bolagsstämma 2015 |
| 2015-10-30 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-20 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-29 | - | Kvartalsrapport 2015-Q1 |
| 2015-05-18 | - | Årsstämma |
| 2015-04-29 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2015-02-18 | - | Bokslutskommuniké 2014 |
| 2014-11-19 | - | Kvartalsrapport 2014-Q3 |
| 2014-10-13 | - | Extra Bolagsstämma 2014 |
| 2014-08-20 | - | Kvartalsrapport 2014-Q2 |
| 2014-04-14 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-03 | - | Split GUARD 1:5 |
| 2014-03-26 | - | X-dag ordinarie utdelning GUARD 0.00 SEK |
| 2014-03-25 | - | Årsstämma |
| 2014-02-21 | - | Bokslutskommuniké 2013 |
| 2013-11-12 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-15 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-22 | - | Årsstämma |
| 2013-05-15 | - | Kvartalsrapport 2013-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Bioteknik |
Guard Therapeutics International AB (publ) (“Guard Therapeutics” or the “Company”) today announced that the number of shares and votes in the Company has changed due to the recently completed Rights Issue (for further information, see the Company’s press release on April 4, 2025).
Through the Rights Issue, the number of shares and votes increased by 7,872,753 shares, amounting to a total of 20,167,631 shares and votes in Guard Therapeutics. External investors who had undertaken to guarantee the Rights Issue chose to receive the guarantee commission in cash.
For further information, please contact:
Tobias Agervald, CEO
Telephone: +46 8 670 65 51
E-mail: info@guardtherapeutics.com
About Guard Therapeutics
Guard Therapeutics is a Swedish clinical-stage biotechnology company that identifies and develops new therapies for diseases with a large unmet medical need, focusing on different forms of kidney disease. The company’s candidate drugs are based on the endogenous protein alpha-1-microglobulin. Guard Therapeutics is listed on Nasdaq First North Growth Market Stockholm (ticker: GUARD).
Certified Adviser is Svensk Kapitalmarknadsgranskning AB, www.skmg.se.